Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 diciembre 2012

AMERICAN JOURNAL OF ROENTGENOLOGY. Fotemustine Chemoembolization of Hepatic Metastases From Uveal Melanoma: A Retrospective Single-Center Analysis

Gundula Edelhauser, Nikolaus Schicher, Dominik Berzaczy, Dietrich Beitzke, Christoph Höeller, Johannes Lammer and Martin Funovics

OBJECTIVE. The purpose of the current study was to retrospectively evaluate response and survival in patients with hepatic metastasis from uveal melanoma treated by palliative transarterial chemoembolization (TACE) with fotemustine.

28 noviembre 2013

WORLD JOURNAL OF GASTROENTEROLOGY. Ileal conduit stomal variceal bleeding managed by endovascular embolization

Deng-Hua Yao, Xue-Feng Luo, Biao Zhou and Xiao Li.

Ileal conduit stomal varices are rare, and may result in bleeding. The standard treatment modality for management of this type of hemorrhage has not been established. We present the case of a 70-year-old woman with progressive ileal conduit stomal variceal bleeding which was successfully managed by endovascular embolization via the transjugular transhepatic approach. In conclusion, transjugular transhepatic endovascular embolization is a good choice in patients with ileal conduit stomal variceal bleeding who have failed conservative therapy.

1 diciembre 2013

WORLD JOURNAL OF GASTROENTEROLOGY. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation

Maurizio Pompili, Giampiero Francica, Francesca Romana Ponziani, Roberto Iezzi and Alfonso Wolfango Avolio.

Several therapeutic procedures have been proposed as bridging treatments for patients with hepatocellular carcinoma (HCC) awaiting liver transplantation (LT). The most used treatments include transarterial chemoembolization and radiofrequency ablation. Surgical resection has also been successfully used as a bridging procedure, and LT should be considered a rescue treatment in patients with previous HCC resection who experience tumor recurrence or post-treatment severe decompensation of liver function. The aims of bridging treatments include decreasing the waiting list dropout rate before transplantation, reducing HCC recurrence after transplantation, and improving post-transplant overall survival. To date, no data from prospective randomized studies are available; however, for HCC patients listed for LT within the Milan criteria, prolonging the waiting time over 6-12 mo is a risk factor for tumor spread. Bridging treatments are useful in containing tumor progression and decreasing dropout. Furthermore, the response to pre-LT treatments may represent a surrogate marker of tumor biological aggressiveness and could therefore be evaluated to prioritize HCC candidates for LT. Lastly, although a definitive conclusion can not be reached, the experiences reported to date suggest a positive impact of these treatments on both tumor recurrence and post-transplant patient survival. Advanced HCC may be downstaged to achieve and maintain the current conventional criteria for inclusion in the waiting list for LT. Recent studies have demonstrated that successfully downstaged patients can achieve a 5-year survival rate comparable to that of patients meeting the conventional criteria without requiring downstaging.

01 diciembre 2012

AMERICAN JOURNAL OF ROENTGENOLOGY. Polytetrafluoroethylene-Covered Retrievable Expandable Nitinol Stents for Malignant Esophageal Obstructions: Factors Influencing the Outcome of 270 Patients

Jung-Hoon Park, Ho-Young Song, Jin Hyoung Kim, Hwoon-Yong Jung, Jong-Hoon Kim, Sung-Bae Kim and Heuiran Lee

OBJECTIVE. The purpose of this study was to evaluate the clinical effectiveness of polytetrafluoroethylene (PTFE)–covered retrievable expandable nitinol stents in patients with malignant esophageal strictures and to identify prognostic factors associated with clinical outcomes.

01 diciembre 2013

EURO INTERVENTION. Novel use of NavX three-dimensional mapping to guide renal artery denervation

Sarah Zaman1,2, MBBS; Jim Pouliopoulos1, PhD; Sara Al Raisi1, MBBS; Janice Sullivan1, RN; Aravinda Thiagalingam1, MBBS, PhD; John Swinnen1, MBBS; Pramesh Kovoor1,2*, MBBS, PhD

Aims: Renal artery denervation (RAD) is an effective treatment for resistant hypertension. The Navigation and Visualisation Technology (NavX) system creates three-dimensional (3-D) anatomical maps to guide catheter position and identify ablation sites. This first-in-human study assessed the utility of NavX 3-D mapping for RAD

01 diciembre 2012

AMERICAN JOURNAL OF ROENTGENOLOGY. Incidental Findings at Initial Imaging Workup of Patients With Prostate Cancer: Clinical Significance and Outcomes

Azadeh Elmi, Shahin Tabatabaei, Saman Shafaat Talab, Sandeep S. Hedgire, Kai Cao and Mukesh Harisinghani

OBJECTIVE. The purpose of this article is to evaluate the frequency and clinical relevance of incidental findings in patients with prostate cancer who underwent abdominopelvic contrast-enhanced CT examination for initial staging workup.

01 diciembre 2013

EURO INTERVENTION. First-in-man report of a novel dedicated radiofrequency catheter for renal denervation via the transulnar approach

Xiong-Jing Jiang*, MD; Hui Dong, MS; Tuo Liang, MS; Yu-Bao Zou, MD; Bo Xu, MBBS; Run-Lin Gao, MD

Abstract: Renal denervation (RDN) has been shown to be safe and efficacious in reducing blood pressure in patients with resistant hypertension. In the present study, we describe a first-in-man report of the Iberis renal denervation device in a patient who underwent two RDN procedures: one via the femoral artery and one via the transulnar approach. RDN was performed in the patient’s right renal artery using an Iberis catheter via the transulnar approach, as the transfemoral or transradial arteries could not be approached due to their anatomic constraints. In summary, RDN via the transulnar approach is feasible and represents a technical alternative solution in certain patients.

01 octubre 2013

ENDOVASCULAR TODAY. Mynx Vascular Closure Device Early Ambulation Study

Vikranth R. Gongidi, DO; Ahsan Jafir, DO; and Vijay Verma, MD, FACC, FSCAI

Vascular closure devices (VCDs) are increasingly used for femoral access closure in cardiac catheterization, in large part because they allow for early ambulation after the procedure. The benefits of early ambulation include improved hospital throughput and earlier dischargeability, resulting in cost savings. In some cases, this early discharge can convert a potential inpatient procedure to an outpatient case. Early ambulation also can improve patient comfort, especially for those with comorbidities (eg, obesity, back pain, etc.) for whom extended time lying flat can be quite painful.

28 octubre 2013

WORLD JOURNAL OF GASTROENTEROLOGY. Resolution of an esophageal leak and posterior gastric wall necrosis with esophageal self-expandable metal stents

Majid A Almadi, Abdulrahman M Aljebreen and Fahad Bamihriz.

Abstract: he use of weight reduction surgeries has increased over the years with a higher proportion of these surgeries being sleeve gastrectomies, this has been associated with some complications including staple line leaks. We report a 32-year-old male who had undergone a laparoscopic gastric band surgery and subsequently a laparoscopic sleeve gastrectomy, this was complicated by both an staple line leak at the gastroesophageal junction as well as a large (> 4 cm) posterior gastric wall defect due to gastric wall necrosis. We used two co-axially inserted self-expandable stents (SEMS) in the management of this patient, 5 stents were used over repeated endoscopy sessions and 20 wk. Both defects had resolved without the need for surgical intervention.This is the first reported case were SEMS are used for both a staple line leak as well as a gastric wall defect. We also review the literature on the use of SEMS in the management of leaks post weight reduction surgeries.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.